1
|
Cao YL, Sun C, Xi JY, Luo SS, Hu JN, Zheng YS, Qiao K, Lu JH, Lin J. [Clinical features of peripheral neuropathy with livedo reticularis: an analysis of seven cases]. Zhonghua Yi Xue Za Zhi 2024; 104:218-221. [PMID: 38220448 DOI: 10.3760/cma.j.cn112137-20231024-00882] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/16/2024]
Abstract
The clinical characteristics, auxiliary examinations, skin and neuropathological features of 7 patients who had reticular cyanosis with peripheral neuropathy from the Department of Neurology, Huashan Hospital, Fudan University from January 2019 to December 2022 were retrospectively analyzed. Among the 7 patients, 5 were female and 2 were male.The age of onset of peripheral neuropathy was (39.8±21.3) years and the disease duration of peripheral neuropathy was (2.7±2.3) years. Three patients had acute onset and 4 patients had chronic onset. All the patients had limb numbness, with limb weakness in 6 patients and pain in 5 cases. Neuroelectrophysiological examination revealed 1 case of mononeuropathy, 2 cases of polyneuropathy, 2 cases of peripheral neuropathy, and 2 cases of sensory neuron neuropathy. Skin biopsy was performed in 3 patients, which presented hyperplasia and expansion of blood vessels in the dermis with lymphocyte infiltration. Nerve biopsy was performed in 3 patients, indicating axonal damage. Reticular cyanosis with peripheral neuropathy characterizes with numbness and weakness of limbs, most of which were accompanied by pain. Electrophysiological changes are in various forms. The pathological changes are dominated by the damage of axonal.
Collapse
Affiliation(s)
- Y L Cao
- Department of Neurology, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China
| | - C Sun
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J Y Xi
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - S S Luo
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J N Hu
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - Y S Zheng
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - K Qiao
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J H Lu
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J Lin
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| |
Collapse
|
2
|
Guo QJ, Gu Y, Ouyang J, Yu LL, Zhang YZ, Rao JQ, Luo SS, Xu WY. [Summary of the best evidence on exercise for the prevention and treatment of diabetic foot]. Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi 2023; 39:671-678. [PMID: 37805697 DOI: 10.3760/cma.j.cn501225-20220822-00354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 10/09/2023]
Abstract
Objective: To summarize the best evidence on exercise for the prevention and treatment of diabetic foot. Methods: A bibliometric approach was used. Systematic searches were carried out to retrieve all the publicly published evidences till July 2022 on exercise for the prevention and treatment of diabetic foot, including guidelines, evidence summary, recommended practices, expert consensus, systematic review, and original research, from foreign language databases including BMJ Best Practice, UpToDate, Joanna Briggs Institute Evidence-Based Practice Database, Cochrane Library, Embase, PubMed, Guideline International Network, National Guideline Clearinghouse, Chinese databases including China National Knowledge Infrastructure, Wanfang Database, VIP Database, China Biology Medicine disc, China Clinical Guidelines Library, and the official websites of relevant academic organizations including National Institute for Health and Care Excellence of the United Kingdom, Registered Nurses' Association of Ontario of Canada, the International Working Group on the Diabetic Foot, International Diabetes Federation, American College of Sports Medicine, American Diabetes Association, and Chinese Diabetes Society. The literature was screened and evaluated for the quality, from which the evidences were extracted and evaluated to summarize the best evidences. Results: Nine guidelines, three expert consensuses, one evidence summary (with two systematic reviews being traced), two systematic reviews, 6 randomized controlled trials were retrieved and included, with good quality of literature. Totally 33 pieces of best evidences on exercise for the prevention and treatment of diabetic foot were summarized from the aspects of appropriate exercise prevention of diabetic foot, exercise therapy of diabetic foot, precautions for exercise, health education, and establishment of a multidisciplinary limb salvage team. Conclusions: Totally 33 pieces of best evidences on exercise for the prevention and treatment of diabetic foot were summarized from 5 aspects, providing decision-making basis for clinical guidance on exercise practice for patients with diabetic foot.
Collapse
Affiliation(s)
- Q J Guo
- School of Nursing, Guizhou Medical University, Guiyang 550004, China
| | - Y Gu
- Nursing Department, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| | - J Ouyang
- Central Sterile Supply Department, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| | - L L Yu
- School of Nursing, Guizhou Medical University, Guiyang 550004, China
| | - Y Z Zhang
- School of Nursing, Guizhou Medical University, Guiyang 550004, China
| | - J Q Rao
- Emergency Intensive Care Unit, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| | - S S Luo
- School of Nursing, Guizhou Medical University, Guiyang 550004, China
| | - W Y Xu
- Neurology Department, Affiliated Hospital of Guizhou Medical University, Guiyang 550004, China
| |
Collapse
|
3
|
Luo SS, Zhu H, Huang HF, Ding GL. Sex differences in glycolipidic disorders after exposure to maternal hyperglycemia during early development. J Endocrinol Invest 2023:10.1007/s40618-023-02069-5. [PMID: 36976483 DOI: 10.1007/s40618-023-02069-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/08/2022] [Accepted: 03/10/2023] [Indexed: 03/29/2023]
Abstract
PURPOSE The aim of this review was to summarize sex differences in glycolipid metabolic phenotypes of human and animal models after exposure to maternal hyperglycemia and overview the underlying mechanisms, providing a new perspective on the maternal hyperglycemia-triggered risk of glycolipidic disorders in offspring. METHODS A comprehensive literature search within PubMed was performed. Selected publications related to studies on offspring exposed to maternal hyperglycemia investigating the sex differences of glycolipid metabolism were reviewed. RESULTS Maternal hyperglycemia increases the risk of glycolipid metabolic disorders in offspring, such as obesity, glucose intolerance and diabetes. Whether with or without intervention, metabolic phenotypes have been shown to exhibit sex differences between male and female offspring in response to maternal hyperglycemia, which may be related to gonadal hormones, organic intrinsic differences, placenta, and epigenetic modifications. CONCLUSION Sex may play a role in the different incidences and pathogenesis of abnormal glycolipid metabolism. More studies investigating both sexes are needed to understand how and why environmental conditions in early life affect long-term health between male and female individuals.
Collapse
Affiliation(s)
- S-S Luo
- School of Medicine, The International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University, Shanghai, China
- Shanghai Key Laboratory of Embryo Original Diseases, Shanghai, China
| | - H Zhu
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China
- Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences, Shanghai, China
| | - H-F Huang
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China
- Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences, Shanghai, China
| | - G-L Ding
- Obstetrics and Gynecology Hospital, Institute of Reproduction and Development, Fudan University, Shanghai, China.
- Research Units of Embryo Original Diseases, Chinese Academy of Medical Sciences, Shanghai, China.
| |
Collapse
|
4
|
Yang S, Huan X, Yan C, Song J, Luo SS, Lu JH, Zhao CB. [Efficacy of thymectomy in patients with non-thymoma myasthenia gravis]. Zhonghua Yi Xue Za Zhi 2020; 100:2297-2302. [PMID: 32746602 DOI: 10.3760/cma.j.cn112137-20191206-02664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To compare the efficacy between thymectomy plus prednisone and prednisone alone in patients with non-thymoma myasthenia gravis (MG). Methods: Thirty generalized MG patients without thymoma who underwent thymectomy were collected as the operation group, and thirty-nine patients without thymectomy who were treated with prednisone alone were matched as the control group. The start point was the enrollment time and the endpoint event was the "clinical remission" (including complete stabilization remission, drug remission, and poor performance). The survival curve was used to analyze the difference of endpoint event time between the two groups. Besides, a 12-month follow-up study was conducted to compare relevant clinical indicators between the two groups. Results: There was no significant difference in the occurrence time of endpoint events between the two groups (P=0.614). After 6-month follow-up, no significant differences were found in clinical remission rate, the dosage of pyridostigmine bromide and prednisone, the peak dosage of prednisone, the use of other immunosuppressive medications and the rate of hospitalization for exacerbation of disease between the two groups (all P>0.05). After 12-month follow-up, the dosage of prednisone and pyridostigmine in the operation group was significantly lower than that in the control group (5(0,10)mg/d vs 7.5(5,10)mg/d and 30(0,105)mg/d vs 90(15,180)mg/d; P=0.038, 0.032). Conclusion: In patients with mild to moderate non-thymoma generalized MG, thymectomy does not achieve faster remission, but it does reduce the long-term dosage of prednisone and bromopyrazine.
Collapse
Affiliation(s)
- S Yang
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China [Yang Song is now working at the Department of Neurology, the Third Affiliated Hospital of Soochow University (Changzhou First People's Hospital), Changzhou 213003, China]
| | - X Huan
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - C Yan
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J Song
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - S S Luo
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - J H Lu
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| | - C B Zhao
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
| |
Collapse
|
5
|
Duan FF, Zhou YB, Li HT, Gao YQ, Zhang YL, Luo SS, Kang CY, Liu JM. [Institutional delivery rate in minority inhabited areas of China from 1996 to 2017]. Zhonghua Yi Xue Za Zhi 2019; 99:2135-2140. [PMID: 31315386 DOI: 10.3760/cma.j.issn.0376-2491.2019.27.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
Objective: To describe the secular trends of institutional delivery (ID) rate in minority inhabited areas of China from 1996 to 2017 according to national health policies. Methods: The number of live births and IDs for each county/district in 31 provinces of China were derived from the datasets collected by the Office for National Maternal & Child Health Statistics of China. Information on health policies and ethnical areas was derived from official governmental websites. The calendar years were divided into three periods: pre-program period (1996 to 1999), program implementation period (2000 to 2008) and post-program period (2009 to 2017). Minority autonomous regions, autonomous prefectures, and autonomous counties were defined as minority inhabited areas. The ethnic that a county was classified into was determined by a principle of close proximity to the name of the county or its next higher level administrative division. A total of 700 counties in minority inhabited areas were included in the analysis. Results: A total of 45 684 265 live births including 35 098 855 delivered in institutions were analyzed. The ID rate in minority inhabited areas was 37.5% (696 221/1 856 164) in 1996 and 99.2% (2 371 209/2 390 131) in 2017, with an annual growth rate of 4.7%. During the 22-years period, the ID rates in the eastern, central and western regions increased simultaneously, with the annual growth rates of 3.1%, 4.2% and 4.9% respectively. The difference between the eastern and western regions decreased steadily from 16% in 1996 to <1% in 2017 and the difference between the urban and rural areas decreased from 32.1% in 1996 to <1% in 2017. Besides, the ID rates in Tibetan and Yi inhabited areas with lower baseline levels increased 73 and 63 percentage points respectively. The number of counties with the ID rate of <96% were substantially reduced from 589 in 1996 to 72 in 2017; the 71 counties were all located in national deep poverty-stricken areas named Three Districts and Three States, predominantly involving Tibetan (58), Yi (6), Uygur (2) and Lisu (2) ethnics. Conclusion: During the past 22 years, the ID rate in minority inhabited areas in China has dramatically increased, achieving the goal of 2 020 ahead of schedule, but there remains a few western counties where ID rates are still<96%, indicating that minority inhabited western areas should be focused in developing national policies concerning institutional delivery.
Collapse
Affiliation(s)
- F F Duan
- Institute of Reproductive & Child Health/National Health Commission Key Laboratory of Reproductive Health/Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Y B Zhou
- Institute of Reproductive & Child Health/National Health Commission Key Laboratory of Reproductive Health/Office for Maternal & Child Health Statistics of China/Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - H T Li
- Institute of Reproductive & Child Health/National Health Commission Key Laboratory of Reproductive Health/Office for Maternal & Child Health Statistics of China/Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - Y Q Gao
- Office for Maternal & Child Health Statistics of China/Department of Maternal and Child Health, School of Public Health, Peking University, Beijing 100191, China
| | - Y L Zhang
- Institute of Reproductive & Child Health/National Health Commission Key Laboratory of Reproductive Health/Office for Maternal & Child Health Statistics of China/Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| | - S S Luo
- Office for Maternal & Child Health Statistics of China/Department of Maternal and Child Health, School of Public Health, Peking University, Beijing 100191, China
| | - C Y Kang
- Office for Maternal & Child Health Statistics of China/Department of Maternal and Child Health, School of Public Health, Peking University, Beijing 100191, China
| | - J M Liu
- Institute of Reproductive & Child Health/National Health Commission Key Laboratory of Reproductive Health/Office for Maternal & Child Health Statistics of China/Department of Epidemiology & Biostatistics, School of Public Health, Peking University, Beijing 100191, China
| |
Collapse
|
6
|
Klaiber M, Hatsagortsyan KZ, Wu J, Luo SS, Grugan P, Walker BC. Limits of Strong Field Rescattering in the Relativistic Regime. Phys Rev Lett 2017; 118:093001. [PMID: 28306283 DOI: 10.1103/physrevlett.118.093001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/03/2016] [Indexed: 06/06/2023]
Abstract
Recollision for a laser driven atomic system is investigated in the relativistic regime via a strong field quantum description and Monte Carlo semiclassical approach. We find the relativistic recollision energy cutoff is independent of the ponderomotive potential U_{p}, in contrast to the well-known 3.2U_{p} scaling. The relativistic recollision energy cutoff is determined by the ionization potential of the atomic system and achievable with non-negligible recollision flux before entering a "rescattering free" interaction. The ultimate energy cutoff is limited by the available intensities of short wavelength lasers and cannot exceed a few thousand Hartree, setting a boundary for recollision based attosecond physics.
Collapse
Affiliation(s)
- M Klaiber
- Max-Planck-Institut für Kernphysik, Saupfercheckweg 1, 69117 Heidelberg, Germany
| | - K Z Hatsagortsyan
- Max-Planck-Institut für Kernphysik, Saupfercheckweg 1, 69117 Heidelberg, Germany
| | - J Wu
- State Key Laboratory of Precision Spectroscopy, East China Normal University, Shanghai 200062, China
| | - S S Luo
- Department of Physics and Astronomy, University of Delaware, Newark, Delaware 19716, USA
| | - P Grugan
- Department of Physics and Astronomy, University of Delaware, Newark, Delaware 19716, USA
| | - B C Walker
- Department of Physics and Astronomy, University of Delaware, Newark, Delaware 19716, USA
| |
Collapse
|
7
|
Mishima T, Kurasawa G, Ishikawa G, Mori M, Kawahigashi Y, Ishikawa T, Luo SS, Takizawa T, Goto T, Matsubara S, Takeshita T, Robinson JM, Takizawa T. Endothelial Expression of Fc Gamma Receptor IIb in the Full-term Human Placenta. Placenta 2007; 28:170-4. [PMID: 16600368 DOI: 10.1016/j.placenta.2006.01.024] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/01/2005] [Revised: 01/31/2006] [Accepted: 01/31/2006] [Indexed: 11/29/2022]
Abstract
In the third trimester, human placental endothelial cells express Fc gamma receptor IIb (FcgammaRIIb). This expression is unique because FcgammaRIIb is generally expressed on immune cells and is typically undetectable in adult endothelial cells. Recently, we found a novel FcgammaRIIb-defined, IgG-containing organelle in placental endothelial cells; this organelle may be a key structure for the transcytosis of IgG across the endothelial layer. In this study, we verify the expression of FcgammaRIIb in endothelial placenta cells and use reverse transcriptase-polymerase chain reaction (RT-PCR) and sequencing analyses to define the expressed FCGR2B mRNA transcript variant. We also investigated the distribution of FCGR2B mRNA and protein within the vascular tree of the full-term human placenta by RT-PCR and quantitative microscopy. The mRNA sequence of FCGR2B expressed specifically in placental endothelial cells is that of transcript variant 2. FcgammaRIIb expression and synthesis occur throughout the placental vascular tree but do not extend into the umbilical cord. This study provides additional information on FcgammaRIIb expression in the human placenta.
Collapse
Affiliation(s)
- T Mishima
- Department of Molecular Anatomy, Nippon Medical School, 1-1-5 Sendagi, Tokyo 113-8602, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Ni HX, Luo SS, Shao GM. [Effect of Acanthopanax senticosus injection on plasma and urinary endothelin in early stage of diabetic nephropathy]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2001; 21:105-7. [PMID: 12577391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
OBJECTIVE To explore the mechanism of Acanthopanax senticosus (AS) on diabetic nephropathy (DN) patients by observing its effect on urinary albumin excretion (UAE) and renal endothelin (ET) metabolism. METHODS Forty-seven patients of diabetes mellitus (DM) type 2 with persistent microalbuminuria and normotension were randomly divided into two groups, the conventional treatment group (control group) and the AS treatment group. The treatment course was 8 weeks. The changes of UAE, plasma and urinary ET levels before and after treatment were observed. RESULTS Levels of UAE, plasma and urinary ET lowered significantly (P < 0.01) in the AS groups, while no significant change was shown in the control group. By correlation analysis, the decrement of UAE was positively correlated with the decrement of urinary and plasma ET levels (r = 0.72, P < 0.01 and r = 0.63, P < 0.01). CONCLUSION The protective effect of AS injection on DN is probably correlated with its inhibition on ET synthesis in kidney.
Collapse
Affiliation(s)
- H X Ni
- Department of Endocrinology, Zhejiang Provincial Hospital of TCM, Hangzhou 310006
| | | | | |
Collapse
|
9
|
Abstract
Thrombopoietin (TPO), a major cytokine involved in megakaryocytopoiesis/thrombopoiesis, may be effective for treatment of the thrombocytopenia associated with myelodysplastic syndromes (MDS). However, it has been unclear whether TPO stimulates proliferation of MDS blasts, as observed in de novo acute myeloid leukemia. This study examined this concern. When marrow cells from 37 MDS cases were cultured with or without recombinant human PEGylated TPO, TPO increased the blast number (stimulation index > or =1.5) in 9 of 16 high-risk MDS cases (refractory anemia with excess blasts [RAEB] and RAEB in transformation) and 4 of 10 cases with MDS transformed to acute leukemia (MDS-AL), but none of 11 cases with low-risk MDS (RA and RA with ringed sideroblasts). When the cell cycle of cultured cells was determined by three-color flow cytometry, TPO activated the cell cycle of MDS cells (causing a decrease in G(0)-phase cells) in most of the cases whose blast number increased in response to TPO. Reverse transcriptase-polymerase chain reaction analysis detected TPO receptor messenger RNA in purified blasts from all six cases examined, irrespective of the response of their blasts to TPO in culture. Analysis of the patients' characteristics identified a high-serum lactate dehydrogenase (LDH) value as being associated with blast proliferation in high-risk MDS cases (p = 0.0036). We conclude that TPO stimulates in vitro proliferation of blasts from a fraction of MDS patients. High-risk MDS patients, especially those who have a high-serum LDH value, and MDS-AL patients should be monitored with particular care in clinical trials of TPO for MDS.
Collapse
Affiliation(s)
- S S Luo
- Third Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
| | | | | | | | | |
Collapse
|
10
|
|
11
|
Wang MY, Luo SS, Qi ZW. Studies on bradykinin potentiating peptide (BPP) from venom of Zhejiang pit viper (Agkistrodon halys pallas)--relationship between structure and function of BPP. Sci Sin B 1983; 26:716-724. [PMID: 6635651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The structure of the bradykinin potentiating peptide component BPP1 from a 70% methanol extract of the lyophilized powder of pit viper from Zhejiang Province is shown as follows: (formula see text) When the pyroglutamyl residue was removed by pyroglutamate aminopeptidase, the activity of BPP1 was enhanced two-fold but decreased gradually during the course of Edman degradation. The above facts show that the structure integrity of the C-terminal is absolutely necessary for the activity of BPP1.
Collapse
|